Xunda Ji

Shanghai Jiao Tong University — China

Medicine · Health Sciences

21h-index1.5kcitations62works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ocular Oncology and Treatments(40), Brain Metastases and Treatment(13), Retinopathy of Prematurity Studies(11), Corneal Surgery and Treatments(8), Retinal Diseases and Treatments(7)

Publications58 total

Clinical characteristics and management outcomes of secondary tumour-associated neovascularization in retinoblastoma patients
Retina·2025
RB-Care: An Artificial Intelligence System for Automatic Quantitative Assessment and Surveillance of Retinoblastoma
Translational Vision Science & Technology·2025Open Access
Human induced pluripotent stem cells derived from peripheral blood mononuclear cells of a retinoblastoma patient
Stem Cell Research·2025Open Access
Diminished MYCN Dosage Endows Cavitary Transformation in Retinoblastoma
Ophthalmology Science·2025Open Access
Clinical Stage of Retinoblastoma Based on Presenting Signs of 4578 Patients from 121 Countries
Ophthalmology·2025· 2 cited
Lag Time Between Onset of First Symptom and Treatment of Retinoblastoma: Outcomes at Three Years from Recruitment
Seminars in Ophthalmology·2025· 3 cited
Clinical characteristics and management outcomes of pediatric patients with Coats disease complicated with retinoschisis (retinal cyst)
Frontiers in Medicine·2025· 1 citedOpen Access
Primary Enucleation for Intraocular Unilateral Retinoblastoma Can Save Life in Lower-Income Settings
Seminars in Ophthalmology·2024Open Access
Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma
Investigative Ophthalmology & Visual Science·2024Open Access
Clinical features and image manifestations of recurrent retinoblastoma with limb bone metastasis and without CNS involvement
2024Open Access
Retinoblastoma in Asia
Ophthalmology·2023· 16 citedOpen Access
Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial
The Lancet Child & Adolescent Health·2023· 35 cited
Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries
British Journal of Ophthalmology·2022· 8 citedOpen Access
LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis
Ocular Immunology and Inflammation·2022· 3 cited
Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China
Frontiers in Medicine·2022· 12 citedOpen Access
Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis
Cancer Management and Research·2022· 1 citedOpen Access
The role of maternal age & birth order on the development of unilateral and bilateral retinoblastoma: a multicentre study
Eye·2022· 4 citedOpen Access
[Retracted] The Optos 200Tx Scanning Laser Ophthalmoscope Application in Retinoblastoma Patients’ Follow‐Up
BioMed Research International·2022· 1 citedOpen Access
Defining High-risk Retinoblastoma
JAMA Ophthalmology·2021· 40 citedOpen Access
Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma
Eye·2021· 11 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Peiquan Zhao(23), Jesse L. Berry(10), Swathi Kaliki(10), Nathalie Cassoux(9), Ido Didi Fabian(9), Richard Bowman(9), Yu Xu(8), Tatiana L. Ushakova(8), Nick Astbury(8), Sharon Blum(8), Matthew J. Burton(8), Jia-Kai Li(7), Riffat Rashid(7), Tingyi Liang(7), Sadik Taju Sherief(7), Covadonga Bascarán(7), Allen Foster(7), Nir Gomel(7), Andrew W. Stacey(7), Marcia Zondervan(7)